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INTRODUCTION
Neurosecretion of gonadotropin releasing hormone 
(GnRH) is episodic (one pulse every 90-100 min) which 
stimulates LH
LH in turn stimulates episodic release of testosterone (T) 
in the testes (Turek et al, 1994). 
High intra-testicular T is a requisite for spermatogenesis 
in the testis. Hence episodic secretion of all the three 
hormones is essential for fertility. 
Clinical trials have demonstrated the contraceptive 
potential of feedback-inhibition of endogenous T 
production (Grimes et al, 2004).
Supplementation of endogenous T is currently incapable 
of restoring fertility. (exogenous T delivery-CONTINUOUS) 
Intensive sampling of peripheral blood, at intervals of 2-
10 minutes (Heroic!)
Established computational models of the hypothalamus-
pituitary-gonad- (Veldhuis et al, 1998) 
Test the hypothesis- inhibition of GnRH and/or LH 
secretion by T (pulsatile?) 
A long-standing evidence shows that such depriviation, 
results in atrophy of the pituitary (Drewett et al, 1993). 
This report addresses the pulsatile approach to feedback-
inhibition and tests the hypothesis of episodic 
interference in HPT axis in silico and in vivo. The model 
addresses the effect of chronic GnRH deprivation on the 
viability of pituitary gonadotrophes which has been 
illustrated to have in vivo correlation. 
OBJECTIVES
METHODS
COMPUTATIONAL MODEL
HORMONE SECRETIONS AND CONCENTRATIONS 
OVER 4 MONTHS
HORMONE SECRETIONS AND 
CONCENTRATIONS/DAY
SUSTAINED AND PULSATILE T DELIVERY 
SIMULATIONS
MODEL PREDICTED GnRH SECRETION IN PRESENCE OF VITALITY FUNCTION AND 
VIABILITY OF LH GONADOTROPES
CONCLUSIONS
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¾ To implement a computational model of male 
reproductive hormone secretion and modify it further 
for suggesting a parsimonious, stand-alone male 
contraceptive regimen using T alone. 
¾ To test certain hypotheses about male contraception 
using exogenous T alone. 
¾ To test the contraceptive efficacy of the prepared 
formulations delivering a pulsatile profile.
¾ The model of the HPT axis (Veldhuis et al, 1998) was 
implemented using MATLAB 6.5 platform in 
collaboration with IIT, Kanpur. Basal and pulsatile
secretion rates of GnRH, LH and T were rebuilt from 
observed plasma hormone concentration time series.
¾ Data depicting the periodicity in the HPT axis over 4 
months was generated to test the efficacy of reported 
and fabricated T delivery systems in silico.
¾ Simulations were done for sustained and pulsatile
delivery of T alone as well as  marketed formulations 
delivering T using the above model.
¾ Formulation of a ‘viability function’ describing the 
degeneration and repopulation of LH-producing cells in 
the pituitary and evaluation of gonadotrophe viability in 
rats after prolonged administration of pulsatile external 
T .
¾ The effects of the regimen using fabricated systems on 
spermatogenic status and reproductive capacity have 
been  assessed by studying testicular histology.
MATLAB 6.5 PLATFORM
Pulsatile secretion
•Mass accumulation
•Pulse shape
•Pulse generator
•Stochastic Differential Eqs
•Biological variability
•Experimental variations
•Interface functions
•Circadian rhythm
DISCUSSION
¾The predicted profiles maintain pulsatility
and a circadian rhythm, showing the 
dynamic nature of the model. Intervention of 
the HPT axis by transdermal patches 
delivering T, led to suppression of all three 
hormone concentrations and secretions with 
loss of pulsatility in them. The simulated 
construct for 4 months was dynamic in itself 
with proper suppression shown on 
application of external T due to its feedback 
on succeeding processes. 
¾Pulsatile administration of T injections 
amounting to a total of only 38.4 μg of T a 
day gave better suppression of GnRH
secretion in comparison to a single daily dose 
of 300 μg of MENT (T analog).
¾Pulsatile administration of a smaller dose of 
T suppresses the pulse generator to a greater 
extent than pulsatile administration of a 
larger dose of MENT, probably due to more 
rapid changes in instantaneous T 
concentrations.
¾The secretion and concentration of LH and T 
decrease during 4-month T regimen and 
pulsatile, baseline T is maintained 
throughout this period indicating suitability 
of the regimen for contraception.
¾Pulsatile T acts at the step of the conversion 
of round spermatids between stages VII and 
VIII which is not restored even after 30 days 
of withdrawal of  T treatment. 
¾The extent of apoptosis of LH gonadotropes
in rats on day 136 (after 4 weeks of recovery) 
correlates with suppression of LH secretion 
as proposed by model after T-treatment. 
¾ The dynamic nature of the model includes 
the ability to self correct in anticipation of 
expected T concentration in the past. This 
also indicates the need for contraceptive T 
regimens to be variable rather than 
repetitive, in addition to being pulsatile.
¾ Incorporation of the vitality function in 
the model allows the prediction of a 
“holiday period” in the contraceptive 
regimen, during which exogenous T would 
not be needed to protect from conception.
¾ Incremented disruption of 
spermatogenesis is observed  in T treated 
animals as compared to sham-treated 
animals. 
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EFFICACY OF PULSATILE T DELIVERY SYSTEMS: 
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